The mechanisms underlying synergy between checkpoint blockade and anti-angiogenic therapy remain elusive. In this issue of Cancer Cell, Guo et al. analyze hepatocellular carcinoma patients treated with anti-PD-1 and lenvatinib, identifying a circulating CD8+ T cell population critical for treatment efficacy. Engaging these cells could enhance immunotherapy across other settings.
This ESMO Webinar Series is available to all ESMO Members.
2025 BSH Paediatric Special Interest Group Meeting
An NDA has been submitted to the FDA seeking the approval of TAR-200 for BCG-unresponsive high-risk NMIBC with CIS, with or without papillary tumors.
There is an urgent need to globally strengthen cancer-care systems considering projections that cancer cases will substantially increase during the coming years, said global leaders…
On Jan 20, 2025, US President Donald Trump issued an executive order to withdraw the USA from WHO. The move could jeopardise public health care…
Marion Subklewe, MD, Ludwig-Maximilians-University of Munich, Munich, Germany, shares her excitement for the 19th International Symposium on Acute Leukemias (ISALXIX), taking place on March 16-19,…
We summarize results of a pooled analysis from a multicenter, open-label, phase I/II trial published by Cortes et al. evaluating the effectiveness and tolerability of…
For patients aged 50 years or older and at 3 years post diagnosis, less frequent mammograms were non-inferior compared with annual mammograms for breast cancer-specific…
The International Journal of Cancer is a cancer journal from the Union for International Cancer Control covering experimental and clinical cancer research.
A woman in her 40s presented with a 3-month history of abdominal and pelvic pain, nausea, and vomiting. Ultrasound revealed a 15 cm solid heterogeneous…
